Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Mar;46(3):410–414. doi: 10.1136/gut.46.3.410

Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease

I Nilsson 1, S Lindgren 1, S Eriksson 1, T Wadstrom 1
PMCID: PMC1727870  PMID: 10673306

Abstract

BACKGROUND—Bile tolerant helicobacter species such as H hepaticus and H bilis have frequently been reported to cause hepatitis in mice and other rodents.
AIMS—To investigate the possible pathogenic role of these and other helicobacter species in chronic liver disease in humans.
METHODS—Serum samples from 144 patients with various chronic liver diseases, 30 patients with primary sclerosing cholangitis (PSC), and 48 healthy blood donors were analysed for antibodies against H hepaticus murine strain CCUG 33637 and H pylori strain CCUG 17874. Cell surface proteins of H hepaticus were extracted by acid glycine buffer and used in an enzyme immunoassay (EIA) and immunoblot (IB).
RESULTS—56 of 144 (39%) patients with chronic liver diseases and six of 30 (20%) with PSC showed increased antibody concentrations in the H hepaticus EIA; in the H pylori EIA the numbers were 58% and 13% respectively. Compared with the healthy blood donors the antibody reactivity against the two helicobacter species was not increased (46% and 48% respectively). Patient serum samples retested by the H hepaticus EIA after absorption with sonicated H pylori cells remained positive in 12 of 37 (33%) serum samples. Distinct antibody reactivity to 55-65 kDa proteins was observed by H hepaticus IB, after the absorption step, and was considered specific for H hepaticus. These 12 serum samples were from patients with chronic alcoholic liver disease.
CONCLUSIONS—Antibodies to H hepaticus, often cross reacting with H pylori, occur frequently in patients with chronic liver diseases, with no clear cut relation to specific diagnostic groups. The pathogenic significance of these findings is not known.


Keywords: Helicobacter hepaticus; Helicobacter pylori; chronic liver diseases; primary sclerosing cholangitis; enzyme immunoassay; immunoblot

Full Text

The Full Text of this article is available as a PDF (157.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Protein profiles of the acid glycine extracted cell surface proteins of Helicobacter pylori (lanes 1 and 2) and Helicobacter hepaticus (lanes 3 and 4) separated by SDS-PAGE (8-18%) and stained with silver.

Figure 2  .

Figure 2  

Open in a new tab

Antibody response to cell surface proteins of Helicobacter hepaticus (A and C) and Helicobacter pylori (B and D) was analysed by immunoblotting with serum samples from patients with chronic liver disease (lanes 1 to 11). Lane 12 represents the reference standard. In (C) and (D) serum samples were absorbed with sonicated helicobacter cells.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker D. G. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev. 1998 Apr;11(2):231–266. doi: 10.1128/cmr.11.2.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barton S. G., Winrow V. R., Rampton D. S., Crabtree J. E., Beales I. L., Calam J. Circulating antibodies to the 60-kD heat shock protein (hsp) family in patients with Helicobacter pylori infection. Clin Exp Immunol. 1998 Jun;112(3):490–494. doi: 10.1046/j.1365-2249.1998.00608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blaser M. J. Helicobacters and biliary tract disease. Gastroenterology. 1998 Apr;114(4):840–842. doi: 10.1016/s0016-5085(98)70598-0. [DOI] [PubMed] [Google Scholar]
  4. Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995 May 15;55(10):2111–2115. [PubMed] [Google Scholar]
  5. Broomé U., Olsson R., Löf L., Bodemar G., Hultcrantz R., Danielsson A., Prytz H., Sandberg-Gertzén H., Wallerstedt S., Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996 Apr;38(4):610–615. doi: 10.1136/gut.38.4.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fox J. G., Dewhirst F. E., Shen Z., Feng Y., Taylor N. S., Paster B. J., Ericson R. L., Lau C. N., Correa P., Araya J. C. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology. 1998 Apr;114(4):755–763. doi: 10.1016/s0016-5085(98)70589-x. [DOI] [PubMed] [Google Scholar]
  7. Fox J. G., Drolet R., Higgins R., Messier S., Yan L., Coleman B. E., Paster B. J., Dewhirst F. E. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol. 1996 Oct;34(10):2479–2482. doi: 10.1128/jcm.34.10.2479-2482.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fox J. G., Li X., Yan L., Cahill R. J., Hurley R., Lewis R., Murphy J. C. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun. 1996 May;64(5):1548–1558. doi: 10.1128/iai.64.5.1548-1558.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Franklin C. L., Beckwith C. S., Livingston R. S., Riley L. K., Gibson S. V., Besch-Williford C. L., Hook R. R., Jr Isolation of a novel Helicobacter species, Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J Clin Microbiol. 1996 Dec;34(12):2952–2958. doi: 10.1128/jcm.34.12.2952-2958.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guruge J. L., Schalén C., Nilsson I., Ljungh A., Tyszkiewicz T., Wikander M., Wadström T. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand J Infect Dis. 1990;22(4):457–465. doi: 10.3109/00365549009027078. [DOI] [PubMed] [Google Scholar]
  11. Jalava K., Kaartinen M., Utriainen M., Happonen I., Hänninen M. L. Helicobacter salomonis sp. nov., a canine gastric Helicobacter sp. related to Helicobacter felis and Helicobacter bizzozeronii. Int J Syst Bacteriol. 1997 Oct;47(4):975–982. doi: 10.1099/00207713-47-4-975. [DOI] [PubMed] [Google Scholar]
  12. Kuipers E. J., Pérez-Pérez G. I., Meuwissen S. G., Blaser M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995 Dec 6;87(23):1777–1780. doi: 10.1093/jnci/87.23.1777. [DOI] [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Lecoindre P., Chevallier M., Peyrol S., Boude M., Ferrero R. L., Labigne A. Pathogenic role of gastric Helicobacter sp in domestic carnivores. Vet Res. 1997 May-Jun;28(3):207–215. [PubMed] [Google Scholar]
  15. Lelwala-Guruge J., Nilsson I., Ljungh A., Wadström T. Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA. Scand J Infect Dis. 1992;24(4):457–465. doi: 10.3109/00365549209052632. [DOI] [PubMed] [Google Scholar]
  16. Lin T. T., Yeh C. T., Wu C. S., Liaw Y. F. Detection and partial sequence analysis of Helicobacter pylori DNA in the bile samples. Dig Dis Sci. 1995 Oct;40(10):2214–2219. doi: 10.1007/BF02209009. [DOI] [PubMed] [Google Scholar]
  17. Meillet D., Labrousse F., Benoit M. O., Hernvann A., Musset L., van Amerongen G. Increased serum concentration of IgA2 subclass and IgA2/IgA1 ratio: specific markers of chronic alcoholic abuse? Eur J Clin Chem Clin Biochem. 1997 Apr;35(4):275–279. doi: 10.1515/cclm.1997.35.4.275. [DOI] [PubMed] [Google Scholar]
  18. Nilsson I., Ljungh A., Aleljung P., Wadström T. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol. 1997 Feb;35(2):427–432. doi: 10.1128/jcm.35.2.427-432.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rice J. M. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Emerg Infect Dis. 1995 Oct-Dec;1(4):129–131. doi: 10.3201/eid0104.950404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Siringo S., Vaira D., Menegatti M., Piscaglia F., Sofia S., Gaetani M., Miglioli M., Corinaldesi R., Bolondi L. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci. 1997 Oct;42(10):2024–2030. doi: 10.1023/a:1018849930107. [DOI] [PubMed] [Google Scholar]
  21. Taylor N. S., Fox J. G., Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol. 1995 Jan;42(1):48–52. doi: 10.1099/00222615-42-1-48. [DOI] [PubMed] [Google Scholar]
  22. Tsai C. J. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci. 1998 Jun;43(6):1219–1225. doi: 10.1023/a:1018899506271. [DOI] [PubMed] [Google Scholar]
  23. Verbaan H., Hoffmann G., Lindgren S., Nilsson S., Widell A., Eriksson S. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol. 1998 Jun;33(6):650–655. doi: 10.1080/00365529850171945. [DOI] [PubMed] [Google Scholar]
  24. Ward J. M., Benveniste R. E., Fox C. H., Battles J. K., Gonda M. A., Tully J. G. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Am J Pathol. 1996 Feb;148(2):509–517. [PMC free article] [PubMed] [Google Scholar]
  25. Ward J. M., Fox J. G., Anver M. R., Haines D. C., George C. V., Collins M. J., Jr, Gorelick P. L., Nagashima K., Gonda M. A., Gilden R. V. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst. 1994 Aug 17;86(16):1222–1227. doi: 10.1093/jnci/86.16.1222. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES